Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study - Blauvelt, A; Reich, K; Tsai, T F (J Am Acad Dermatol, 2017)
et al.